Trinity Resources Inc (OTC US:TRRI) surges on news and tiny float

Trinity Resources Inc. (OTC US:TRRI) is up over 1000% and currently trading at $1.8. TRRI currently trades on the OTC board. Yesterday, TRRI announced that following approval by a super majority of Alzex Biomedical Group Inc. (“Alzex”) shareholders obtained on June 30, 2022, it has now entered into a binding Asset purchase agreement (the “Agreement”) with Alzex whereby it will receive all of the assets and intellectual property (the “Assets”) of Alzex Biomedical.

As per the press release, Alzex has devised an innovative therapeutic approach aimed at treating brain diseases by means of highly selective bio precursor drugs (prodrugs). The validity of this approach is evidenced by the company’s progress on Alzheimer’s Disease. The company has developed and patented two families of this new class of drugs, for which “proof of concept” in animal trials (in-vitro) has been established. This new class of drugs do not deploy any biological activity before they have crossed the blood-brain barrier, and hence do not induce significant side effects. The therapy can then target specific receptor sites in a more selective way, forming a superior delivery system through the blood-brain barrier. The therapy can then target specific receptor sites in a more selective way, forming a superior delivery system through the blood-brain barrier. This technology could potentially be applied to any number of brain diseases.

Other hot stocks for the day include Cooper-Standard Holdings Inc (NYSE:CPS), Pineapple Energy Inc. (NASDAQ:PEGY) and Carvana Co. (NYSE:CVNA)

 

For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither WallStreetPR.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at WallStreetPR.com/Disclaimer.

Published by Alan Masterson

Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@wallstreetpr.com) or his Google+ page (https://plus.google.com/103338576216002376250).